Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jun;8(6):401-409.
doi: 10.4155/tde-2017-0010.

The Roles of Bile Acids and Applications of Microencapsulation Technology in Treating Type 1 Diabetes Mellitus

Affiliations
Review

The Roles of Bile Acids and Applications of Microencapsulation Technology in Treating Type 1 Diabetes Mellitus

Louise Woodhams et al. Ther Deliv. .

Abstract

Type 1 diabetes mellitus (T1DM) is an autoimmune disease characterized by the loss of glycemic control. Recent studies have shown significant inflammation and disturbed bile acid homeostasis, associated with T1DM. Bile acids are endogenously produced as a result of cholesterol catabolism in the liver and solely metabolized by gut microflora. This review investigates their potential oral delivery in T1DM using targeted delivery and encapsulation technologies. A sensitive and selective search was carried out using different search engines and databases. Keywords used included diabetes mellitus, bile acids and inflammation. To conclude, bile acids have a significant impact on diabetes symptoms and, when microencapsulated, may be used as an adjunct therapy to supplement T1DM treatment.

Keywords: bile acids; diabetes mellitus; inflammation; microencapsulation; β cells.

Similar articles

See all similar articles

Cited by 2 articles

MeSH terms

LinkOut - more resources

Feedback